An Asian perspective to the problem of osteoporosis

Annals of the Academy of Medicine Singapore

Volumn 31, Issue 1, 2002, Pages 26-29

  Koh, Leonard K H ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Asia; Diagnosis; Epidemiology; Fracture; Osteoporosis Self assessment Tool for Asians (OSTA); Postmenopausal women; Prevention; Treatment

Indexed keywords

AGE DISTRIBUTION; AGED; ETHNIC GROUP; ETHNOLOGY; FEMALE; GENETICS; HUMAN; INCIDENCE; MALE; METHODOLOGY; MIDDLE AGED; OSTEOPOROSIS; PRIMARY PREVENTION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SEX RATIO; SINGAPORE;

AGE DISTRIBUTION; AGED; ETHNIC GROUPS; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; OSTEOPOROSIS; PRIMARY PREVENTION; RISK ASSESSMENT; RISK FACTORS; SEX DISTRIBUTION; SINGAPORE;

EID: 0036366355     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Review

References (75)

1. Cooper C, Campion G, Melton L J 3rd. Hip fractures in the elderly: a world-wide projection. Osteoporos Int 1992; 2:285-9.
2. Gullberg B, Johnell O, Kanis J A. World-wide projections for hip fracture. Osteoporos Int 1997; 7:407-13.
3. Koh L K H, Saw S M, Lee J J M, Leong K H, Lee J. Hip fracture incidence rates in Singapore 1991-1998. Osteoporos Int 2001; 12:311-8.
4. Lau E M, Cooper C. The epidemiology of osteoporosis. The oriental perspective in a world context. Clin Orthop 1996:65-74.
5. Xu L, Lu A, Zhao X H, Chen X S, Cummings S R. Very low rates of hip fracture in Beijing, People's Republic of China the Beijing Osteoporosis Project. Am J Epidemiol 1996; 144:901-7.
6. Lau E, Lee J, Suriwongpaisal P, Saw S, Das D S, Khir A, et al. The incidence of hip fracture in four Asian countries: the Asian Osteoporosis Study (AOS). Osteoporos Int 2001; 12:239-43.
7. Melton L J 3rd, O'Fallon W M, Riggs B L. Secular trends in the incidence of hip fractures. Calcif Tissue Int 1987; 41:57-64.
8. Xu L, Cummings S R, Qin M W, Zhao X H, Chen X S, Nevitt M, et al. Vertebral fractures in Beijing, China: the Beijing Osteoporosis Project. J Bone Miner Res 2000; 15:2019-25.
9. Ross P, Fujiwara S, Huang C, Davis J, Epstein R, Wasnich R, et al. Vertebral fracture prevalence in women in Hiroshima compared to Caucasians or Japanese in the US. Int J Epidemiol 1995; 24:1171-7.
10. Mitra A K, Low C K, Chao A K, Tan S K. Social aspects in patients following proximal femoral fractures. Ann Acad Med Singapore 1994; 23:876-8.
11. Marshall D, Johnell O, Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 1996; 312:1254-9.
12. Goh J, Bose K, Das D S. Pattern of fall and bone mineral density measurement in hip fractures. Ann Acad Med Singapore 1996; 25: 820-3.
13. Huang C, Ross P, Wasnich R. Short-term and long-term fracture prediction by bone mass measurements: a prospective study. J Bone Miner Res 1998; 13:107-13.
14. Lau E M, Woo J, Leung P C, Swaminthan R. Low bone mineral density, grip strength and skinfold thickness are important risk factors for hip fracture in Hong Kong Chinese. Osteoporos Int 1993; 3:66-70.
15. Lau E M, Chan H H, Woo J, Sham A, Leung P C. Body composition and bone mineral density of Chinese women with vertebral fracture. Bone 1996; 19:657-62.
16. Ross P D, He Y, Yates A J, Coupland C, Ravn P, McClung M, et al. Body size accounts for most differences in bone density between Asian and Caucasian women. The EPIC (Early Postmenopausal Interventional Cohort) Study Group. Calcif Tissue Int 1996; 59:339-43.
17. Marquez M, Melton L, Muhs J, Crowson C, Tosomeen A, O'Connor M, et al. Bone density in an immigrant population from Southeast Asia. Osteoporos Int 2001; 12:595-604.
18. Bhudhikanok G S, Wang M C, Eckert K, Matkin C, Marcus R, Bachrach L K. Differences in bone mineral in young Asian and Caucasian Americans may reflect differences in bone size. J Bone Miner Res 1996; 11:1545-56.
19. Cummings S R, Cauley J A, Palermo L, Ross P D, Wasnich R D, Black D, et al. Racial differences in hip axis lengths might explain racial differences in rates of hip fracture. Study of Osteoporotic Fractures Research Group. Osteoporos Int 1994; 4:226-9.
20. Nakamura T, Turner C, Yoshikawa T, Slemenda C, Peacock M, Burr D, et al. Do variations in hip geometry explain differences in hip fracture risk between Japanese and white Americans? J Bone Miner Res 1994; 9:1071-6.
21. Chin K, Evans M C, Cornish J, Cundy T, Reid I R. Differences in hip axis and femoral neck length in premenopausal women of Polynesian, Asian and European origin. Osteoporos Int 1997; 7:344-7.
22. Iki M, Kagamimori S, Kagawa Y, Matsuzaki T, Yoneshima H, Marumo F. Bone mineral density of the spine, hip and distal forearm in representative samples of the Japanese female population: Japanese Population-based Osteoporosis (JPOS) Study. Osteoporos Int 2001; 12:529-37.
23. Yu S, Ho L, Lim B, Sim M. Urinary deoxypyridinoline is a useful biochemical bone marker for the management of postmenopausal osteoporosis. Ann Acad Med Singapore 1998; 27:527-9.
24. Shiraki M, Kushida K, Fukunaga M, Kishimoto H, Taga M, Nakamura T, et al. A double-masked multicenter comparative study between alendronate and alfacalcidol in Japanese patients with osteoporosis. The Alendronate Phase III Osteoporosis Treatment Research Group. Osteoporos Int 1999; 10:183-92.
25. Ongphiphadhanakul B, Piaseu N, Chailurkit L, Rajatanavin R. Suppression of bone resorption in early postmenopausal women by intranasal salmon calcitonin in relation to dosage and basal bone turnover. Calcif Tissue Int 1998; 62:379-82.
26. Chailurkit L, Ongphiphadhanakul B, Piaseu N, Saetung S, Rajatanavin R. Biochemical markers of bone turnover and response of bone mineral density to intervention in early postmenopausal women: an experience in a clinical laboratory. Clin Chem 2001; 47:1083-8.
27. Bauer D C, Browner W S, Cauley J A, Orwoll E S, Scott J C, Black D M, et al. Factors associated with appendicular bone mass in older women. The Study of Osteoporotic Fractures Research Group. Ann Intern Med 1993; 118:657-65.
28. Dargent-Molina P, Favier F, Grandjean H, Baudoin C, Schott A M, Hausherr E, et al. Fall-related factors and risk of hip fracture: the EPIDOS prospective study. Lancet 1996; 348:145-9.
29. Cummings S R, Nevitt M C, Browner W S, Stone K, Fox K M, Ensrud K E, et al. Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med 1995; 332: 767-73.
30. Johnell O, Gullberg B, Kanis J A, Allander E, Elffors L, Dequeker J, et al. Risk factors for hip fracture in European women: the MEDOS Study. Mediterranean Osteoporosis Study. J Bone Miner Res 1995; 10: 1802-15.
31. Ho S C, Leung P C, Swaminathan R, Chan C, Chan S S, Fan Y K, et al. Determinants of bone mass in Chinese women aged 21-40 years. II. Pattern of dietary calcium intake and association with bone mineral density. Osteoporos Int 1994; 4:167-75.
32. Ho S C, Wong E, Chan S G, Lau J, Chan C, Leung P C. Determinants of peak bone mass in Chinese women aged 21-40 years. III. Physical activity and bone mineral density. J Bone Miner Res 1997; 12:1262-71.
33. Ho S C, Chan S S, Woo J, Leung P C, Lau J. Determinants of bone mass in the Chinese old-old population. Osteoporos Int 1995; 5:161-6.
34. Lau E, Donnan S, Barker D J, Cooper C. Physical activity and calcium intake in fracture of the proximal femur in Hong Kong. BMJ 1988; 297:1441-3.
35. Suzuki T, Yoshida H, Hashimoto T, Yoshimura N, Fujiwara S, Fukunaga M, et al. Case-control study of risk factors for hip fractures in the Japanese elderly by a Mediterranean Osteoporosis Study (MEDOS) questionnaire. Bone 1997; 21:461-7.
36. Lau E, Suriwongpaisal P, Lee J, Das D S, Festin M, Saw S, et al. Risk factors for hip fracture in Asian men and women: the Asian osteoporosis study. J Bone Miner Res 2001; 16:572-80.
37. Boonyaratavej N, Suriyawongpaisal P, Takkinsatien A, Wanvarie S, Rajatanavin R, Apiyasawat P. Physical activity and risk factors for hip fractures in Thai women. Osteoporos Int 2001; 12:244-8.
38. Chan H H, Lau E M, Woo J, Lin F, Sham A, Leung P C. Dietary calcium intake, physical activity and the risk of vertebral fracture in Chinese. Osteoporos Int 1996; 6:228-32.
39. Huang C, Ross P, Fujiwara S, Davis J, Epstein R, Kodama K, et al. Determinants of vertebral fracture prevalence among native Japanese women and women of Japanese descent living in Hawaii. Bone 1996; 18:437-42.
40. Chan K M, Pang W S, Ee C H, Ding Y Y, Choo P. Epidemiology of falls among the elderly community dwellers in Singapore. Singapore Med J 1997; 38:427-31.
41. Davis J, Ross P, Nevitt M, Wasnich R. Risk factors for falls and for serious injuries on falling among older Japanese women in Hawaii. J Am Geriatr Soc 1999; 47:792-8.
42. Koh L K H, Ben Sedrine W B, Torralba T P, Kung A, Fujiwara S, Chan S P, et al. A simple tool to identify Asian women at increased risk of osteoporosis. Osteoporos Int 2001; 12:699-705.
43. Lau E M, Woo J, Leung P C, Swaminathan R, Leung D. The effects of calcium supplementation and exercise on bone density in elderly Chinese women. Osteoporos Int 1992; 2:168-73.
44. Lau E, Woo J, Lam V, Hong A. Milk supplementation of the diet of postmenopausal Chinese women on a low calcium intake retards bone loss. J Bone Miner Res 2001; 16:1704-9.
45. Kung A, Luk K, Chu L, Chiu P. Age-related osteoporosis in Chinese: an evaluation of the response of intestinal calcium absorption and calcitropic hormones to dietary calcium deprivation. Am J Clin Nutr 1998; 68: 1291-7.
46. Ongphiphadhanakul B, Rajatanavin R, Chanprasertyothin S, Chailurkit L, Piaseu N, Teerarungsikul K, et al. Vitamin D receptor gene polymorphism is associated with urinary calcium excretion but not with bone mineral density in postmenopausal women. J Endocrinol Invest 1997; 20:592-6.
47. Horiuchi T, Onouchi T, Takahashi M, Ito H, Orimo H. Effect of soy protein on bone metabolism in postmenopausal Japanese women. Osteoporos Int 2000; 11:721-4.
48. Ho S, Chan S, Yi Q, Wong E, Leung P. Soy intake and the maintenance of peak bone mass in Hong Kong Chinese women. J Bone Miner Res 2001; 16:1363-9.
49. Mei J, Yeung S, Kung A. High dietary phytoestrogen intake is associated with higher bone mineral density in postmenopausal but not premenopausal women. J Clin Endocrinol Metab 2001; 86:5217-21.
50. Kaneki M, Hedges S, Hosoi T, Fujiwara S, Lyons A, Crean S, et al. Japanese fermented soybean food as the major determinant of the large geographic difference in circulating levels of vitamin K2. possible implications for hip-fracture risk. Nutrition 2001; 17:315-21 .
51. Lau E M, Kwok T, Woo J, Ho S C. Bone mineral density in Chinese elderly female vegetarians, vegans, lacto-vegetarians and omnivores. Eur J Clin Nutr 1998; 52:60-4.
52. Shiraki M, Ito H, Orimo H. The ultra long-term treatment of senile osteoporosis with 1 alpha-hydroxyvitamin D3. Bone Miner 1993; 20:223-34.
53. Orimo H, Shiraki M, Hayashi Y, Hoshino T, Onaya T, Miyazaki S, et al. Effects of 1 alpha-hydroxyvitamin D3 on lumbar bone mineral density and vertebral fractures in patients with postmenopausal osteoporosis. Calcif Tissue Int 1994; 54:370-6.
54. Shikari M, Kushida K, Yamazaki K, Nagai T, Inoue T, Orimo H. Effects of 2 years' treatment of osteoporosis with 1 alpha-hydroxy vitamin D3 on bone mineral density and incidence of fracture: a placebo-controlled, double-blind prospective study. Endocr J 1996; 43:211-20.
55. Ongphiphadhanakul B, Piaseu N, Tung S, Chailurkit L, Rajatanavin R. Prevention of postmenopausal bone loss by low and conventional doses of calcitriol or conjugated equine estrogen. Maturitas 2000; 34:179-84.
56. Davis J, Ross P, Johnson N, Wasnich R. Estrogen and calcium supplement use among Japanese-American women: effects upon bone loss when used singly and in combination. Bone 1995; 17:369-73.
57. Kung A, Yeung S, Chu L. The efficacy and tolerability of alendronate in postmenopausal osteoporotic Chinese women: a randomized placebo-controlled study. Calcif Tissue Int 2000; 67:286-90.
58. Lau E, Woo J, Chan Y, Griffith J. Alendronate prevents bone loss in Chinese women with osteoporosis. Bone 2000; 27:677-80.
59. Yen M, Yen B, Jang M, Hsu S, Cheng W, Tsai K. Effects of alendronate on osteopenic postmenopausal Chinese women. Bone 2000; 27:681-5.
60. Fujita T, Inoue T, Morii H, Morita R, Norimatsu H, Orimo H, et al. Effect of an intermittent weekly dose of human parathyroid hormone (1-34) on osteoporosis: a randomized double-masked prospective study using three dose levels. Osteoporos Int 1999; 9:296-306.
61. Wasnich R, Ross P, Thompson D, Cizza G, Yates A. Skeletal benefits of two years of alendronate treatment are similar for early postmenopausal Asian and Caucasian women. Osteoporos Int 1999; 9:455-60.
62. Shiraki M, Kushida K, Fukunaga M, Kishimoto H, Kaneda K, Minaguchi H, et al. A placebo-controlled, single-blind study to determine the appropriate alendronate dosage in postmenopausal Japanese patients with osteoporosis. The Alendronate Research Group. Endocr J 1998; 45:191-201.
63. Lim S K, Park Y S, Park J M, Song Y D, Lee E J, Kim K R, et al. Lack of association between vitamin D receptor genotypes and osteoporosis in Koreans. J Clin Endocrinol Metab 1995; 80:3677-81.
64. Tokita A, Matsumoto H, Morrison N A, Tawa T, Miura Y, Fukamauchi K, et al. Vitamin D receptor alleles, bone mineral density and turnover in premenopausal Japanese women. J Bone Miner Res 1996; 11: 1003-9.
65. Kung A, Yeung S, Lau K. Vitamin D receptor gene polymorphisms and peak bone mass in southern Chinese women. Bone 1998; 22:389-93.
66. Kikuchi R, Uemura T, Gorai I, Ohno S, Minaguchi H. Early and late postmenopausal bone loss is associated with Bsml vitamin D receptor gene polymorphism in Japanese women. Calcif Tissue Int 1999; 64: 102-6.
67. Kurabayashi T, Tomita M, Matsushita H, Yahata T, Honda A, Takakuwa K, et al. Association of vitamin D and estrogen receptor gene polymorphism with the effect of hormone replacement therapy on bone mineral density in Japanese women. Am J Obstet Gynecol 1999; 180:1115-20.
68. Ongphiphadhanakul B, Chanprasertyothin S, Payatikul P, Tung S, Piaseu N, Chailurkit L, et al. Oestrogen-receptor-alpha gene polymorphism affects response in bone mineral density to oestrogen in post-menopausal women. Clin Endocrinol (Oxf) 2000; 52:581-5.
69. Kobayashi S, Inoue S, Hosoi T, Ouchi Y, Shiraki M, Orimo H. Association of bone mineral density with polymorphism of the estrogen receptor gene. J Bone Miner Res 1996; 11:306-11.
70. Ho A, Yeung S, Kung A. PvuII polymorphisms of the estrogen receptor alpha and bone mineral density in healthy southern Chinese women. Calcif Tissue Int 2000; 66:405-8.
71. Hosoi T, Miyao M, Inoue S, Hoshino S, Shiraki M, Orimo H, et al. Association study of parathyroid hormone gene polymorphism and bone mineral density in Japanese postmenopausal women. Calcif Tissue Int 1999; 64:205-8.
72. Dohi Y, Iki M, Ohgushi H, Gojo S, Tabata S, Kajita E, et al. A novel polymorphism in the promoter region for the human osteocalcin gene: the possibility of a correlation with bone mineral density in postmenopausal Japanese women. J Bone Miner Res 1998; 13:1633-9.
73. Miyao M, Hosoi T, Emi M, Nakajima T, Inoue S, Hoshino S, et al. Association of bone mineral density with a dinucleotide repeat polymorphism at the calcitonin (CT) locus. J Hum Genet 2000; 45:346-50.
74. Yamada Y, Miyauchi A, Goto J, Takagi Y, Okuizumi H, Kanematsu M, et al. Association of a polymorphism of the transforming growth factor-beta 1 gene with genetic susceptibility to osteoporosis in postmenopausal Japanese women. J Bone Miner Res 1998; 13:1569-76.
75. Ogawa S, Urano T, Hosoi T, Miyao M, Hoshino S, Fujita M, et al. Association of bone mineral density with a polymorphism of the peroxisome proliferator-activated receptor gamma gene: PPARgamma expression in osteoblasts. Biochem Biophys Res Commun 1999; 260:122-6.